Mustang Bio, Inc., a Fortress Biotech Company focused on the development of novel immunotherapies based on proprietary chimeric antigen receptor engineered T cell (CAR T) technology, and St. Jude Children’s Research Hospital, the nation’s leading hospital dedicated to understanding, treating and curing childhood cancer and other life-threatening diseases, announced today that they have partnered.
August 13, 2018
· 8 min read